Literature DB >> 10084302

Oxidative stress can activate the epidermal platelet-activating factor receptor.

J B Travers1.   

Abstract

Platelet-activating factor (1-alkyl-2-acetyl-glycero-phosphocholine) is a lipid mediator that has been implicated in keratinocyte function and cutaneous inflammation. Keratinocytes both synthesize platelet-activating factor and express functional platelet-activating factor receptors linked to calcium mobilization. Oxidative stress to various cells including keratinocytes can also result in the mobilization of intracellular Ca2+, a known stimulus for platelet-activating factor biosynthesis. The ability of the epidermal platelet-activating factor receptors to modulate oxidant-induced signaling was investigated using a unique model system created by retroviral-mediated transduction of the platelet-activating factor receptor-negative epithelial cell line KB with the platelet-activating factor receptor. Treatment of KB cells with the lipid pro-oxidant tert-butyl hydroperoxide induced transient increases in intracellular Ca2+ in a concentration-dependent fashion. Expression of the platelet-activating factor receptor in KB cells lowered the threshold for tert-butyl hydroperoxide-induced Ca2+ flux by an order of magnitude (10 microM in control KB versus 1 microM in KB cells expressing the platelet-activating factor receptors) and increased the peak change in intracellular Ca2+ concentration in response to this lipid hydroperoxide. This augmentation of tert-butyl hydroperoxide-induced Ca2+ mobilization was inhibited by pretreatment with the two competitive platelet-activating factor receptor antagonists CV-6209 and WEB 2086, as well as by the antioxidants vitamin E and 1,1,3,3-tetramethyl-2-thiourea. KB cells synthesized platelet-activating factor and the platelet-activating factor receptor agonist 1-palmitoyl-2-acetyl-glycero-phosphocholine in response to tert-butyl hydroperoxide treatment, suggesting the augmentation of oxidative stress-induced signaling seen in platelet-activating factor receptor-expressing cells was due in part to endogenous platelet-activating factor biosynthesis. These studies suggest involvement of the epidermal platelet-activating factor receptors in oxidant-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10084302     DOI: 10.1046/j.1523-1747.1999.00521.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Enhanced Platelet-Activating Factor Synthesis Facilitates Acute and Delayed Effects of Ethanol-Intoxicated Thermal Burn Injury.

Authors:  Kathleen A Harrison; Eric Romer; Jonathan Weyerbacher; Jesus A Ocana; Ravi P Sahu; Robert C Murphy; Lisa E Kelly; Townsend A Smith; Christine M Rapp; Christina Borchers; David R Cool; Gengxin Li; Richard Simman; Jeffrey B Travers
Journal:  J Invest Dermatol       Date:  2018-05-30       Impact factor: 8.551

2.  Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.

Authors:  Qiwei Zhang; Nico Mousdicas; Qiaofang Yi; Mohammed Al-Hassani; Steven D Billings; Susan M Perkins; Katherine M Howard; Satoshi Ishii; Takao Shimizu; Jeffrey B Travers
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

3.  The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists.

Authors:  Ravi P Sahu; Matthew J Turner; Sonia C DaSilva; Badri M Rashid; Jesus A Ocana; Susan M Perkins; Raymond L Konger; Christopher E Touloukian; Mark H Kaplan; Jeffrey B Travers
Journal:  Carcinogenesis       Date:  2012-04-27       Impact factor: 4.944

4.  Ultraviolet B radiation of human skin generates platelet-activating factor receptor agonists.

Authors:  Jared B Travers; Damien Berry; Yongxue Yao; Qiaofang Yi; Raymond L Konger; Jeffrey B Travers
Journal:  Photochem Photobiol       Date:  2010-05-13       Impact factor: 3.421

Review 5.  Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy.

Authors:  Ildefonso Alves da Silva Junior; Luciana Nogueira de Sousa Andrade; Sonia Jancar; Roger Chammas
Journal:  Clinics (Sao Paulo)       Date:  2018-10-11       Impact factor: 2.365

6.  Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis.

Authors:  Patrick C Hackler; Sarah Reuss; Raymond L Konger; Jeffrey B Travers; Ravi P Sahu
Journal:  Cancer Growth Metastasis       Date:  2014-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.